Clinical Trial Update: Efficacy and Safety of Duloxetine Among Individuals With Depressive Disorder in a 12 Weeks Trial [NA]

View source ↗

Summary

A completed 12-week trial evaluating the efficacy and safety of duloxetine in adults with major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Taichung Veterans General Hospital | Conditions: Major Depressive Disorder | NA | Status: COMPLETED